Concepedia

Efficacy and safety of the combination of metformin, everolimus and exemestane in overweight and obese postmenopausal patients with metastatic, hormone receptor-positive, HER2-negative breast cancer: a phase II study

Clinton Yam, Francisco J. Esteva, Miral Patel, Akshara Singareeka Raghavendra, Naoto T. Ueno, Stacy L. Moulder, Kenneth R. Hess, Girish S. Shroff, Kimberly Higginbotham Koenig, Mariana Chávez‐MacGregor,

Investigational New Drugs · 2019 · 42 citations · 16 references

DOIFull text

Open access

Concepts

References

16

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

E. Eisenhauer, P. Therasse, Jan Bogaerts et al. · European Journal of Cancer · 2008 · 29.5K citations

, , +14

Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults

Eugenia E. Calle, Carmen Rodríguez, Kimberly A Walker-Thurmond et al. · New England Journal of Medicine · 2003 · 7.7K citations · Full text

, , +14

Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast Cancer

José Baselga, Mario Campone, Martine Piccart et al. · New England Journal of Medicine · 2011 · 2.8K citations · Full text

, , +9

Source of Estrogen Production in Postmenopausal Women1

Jerrold Grodin, Pentti K. Siiteri, Paul C. MacDonald · The Journal of Clinical Endocrinology & Metabolism · 1973 · 963 citations

, , +16

Metformin and Pathologic Complete Responses to Neoadjuvant Chemotherapy in Diabetic Patients With Breast Cancer

Sao Jiralerspong, Shana L. Palla, Sharon H. Giordano et al. · Journal of Clinical Oncology · 2009 · 877 citations · Full text

, , +9